Jun 04, 2020
Cure SMA Announces New Funding For Network Of Prominent SMA Clinical Research And Treatment Centers
Apr 28, 2020
Confirmatory Part 2 of FIREFISH Demonstrates Survival and Motor Milestones Not Seen in Natural History in Infants with Type 1 Spinal Muscular Atrophy
Dec 13, 2019
ITF Pharma Announces FDA Approval of Supplemental New Drug Application (sNDA) for TIGLUTIK® (riluzole) Oral Suspension For The Treatment Of Amyotrophic Lateral Sclerosis (ALS) with a Percutaneous Endoscopic Gastronomy (PEG) Feeding Tube
Dec 02, 2019
Bringing Hope to Spinal Muscular Atrophy (SMA) Patients with the Alcyone Lifesciences ThecaFlex DRx(TM) System Breakthrough Device
Sep 17, 2019
Clene Nanomedicine, Inc. Awarded $1.37M AUD Grant from FightMND to Conduct Phase 2 Clinical Study for the Treatment of Amyotrophic Lateral Sclerosis
May 24, 2019
REGENXBIO Announces First FDA Approval of a Gene Therapy Based on Its Proprietary NAV® Technology Platform
Mar 08, 2019
"Information Matrix", with Laurence Fishburne, to Introduce a New Segment on Awareness of Multiple Sclerosis
Feb 28, 2019
ITF Pharma Receives Patient Impact Award for First and Only Easy-To-Swallow Thickened Liquid Treatment for Amyotrophic Lateral Sclerosis (ALS)
Nov 26, 2018
Biohaven Announces FDA Acceptance of 505(b)(2) NDA Filing for BHV-0223, a Novel Sublingual Delivery Form of Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Oct 15, 2018
ITF Pharma Announces Availability Of TIGLUTIK(TM) (riluzole) Oral Suspension For The Treatment Of Amyotrophic Lateral Sclerosis (ALS) In The United States
Oct 12, 2018
Mercaptor Discoveries Announces Positive Preclinical Proof of Concept (POC) in NIH-Funded Studies
Oct 09, 2018
Cure SMA Launches Spinal Muscular Atrophy Care Center Network
Oct 04, 2018
Mitsubishi Tanabe Pharma Canada Announces Canadian Authorization of Radicava(TM) (Edaravone) to Treat ALS
Apr 12, 2018
'Project Revoice' Recreates ALS Ice Bucket Challenge Founder's Voice For Him
Mar 28, 2018
Family of Parkland Shooting Victim Who Wanted to Cure ALS Establishes ALS Research Fund
Mar 15, 2018
Global Neuroprotection Market to Reach Over US$ 47,000.0 Mn by 2025; Constantly Rising Cases of Neurodegenerative Disorders to Fuel Market Growth, Observes Transparency Market Research
Feb 20, 2018
Researchers Demonstrate Therapeutic Antibodies Stabilize Nerve-Muscle Synapses in a Mouse Model of ALS
Feb 08, 2018
Advisory Committee on Heritable Disorders in Newborns and Children Recommends Nationwide Newborn Screening for Spinal Muscular Atrophy
Feb 08, 2018
Global Neuroprotection Report 2018: Drugs, Markets and Companies Analysis, Estimates & Forecasts 2017-2027
Dec 07, 2017
Balas Begins Role as President and CEO of ALS Association